Loading…
LifeVantage Corporation is projected to rise to $7.95 by 2027, a +27% move from its current price of $6.24. LFVN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.98 | $6.24 | $6.52 | +0.03% |
| Jul 14 | $5.87 | $6.24 | $6.64 | +0.06% |
| Jul 15 | $5.79 | $6.25 | $6.73 | +0.09% |
| Jul 16 | $5.73 | $6.25 | $6.82 | +0.12% |
| Jul 17 | $5.67 | $6.25 | $6.89 | +0.15% |
| Jul 18 | $5.62 | $6.25 | $6.95 | +0.17% |
| Jul 19 | $5.57 | $6.25 | $7.02 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.57 | $6.25 | $7.02 | +0.20% |
| Week 2 | $5.32 | $6.27 | $7.37 | +0.41% |
| Week 3 | $5.14 | $6.28 | $7.66 | +0.61% |
| Week 4 | $5.00 | $6.29 | $7.92 | +0.82% |
| Week 5 | $4.87 | $6.30 | $8.15 | +1.02% |
| Week 6 | $4.77 | $6.32 | $8.37 | +1.23% |
| Week 7 | $4.67 | $6.33 | $8.58 | +1.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name.
It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
LifeVantage Corporation (LFVN) operates in the Consumer Defensive category, offering a broad portfolio of nutrigenomic activators, dietary supplements, nootropics, and skin care products internationally. The company markets Protandim, LifeVantage Omega+, ProBio, IC Bright, Daily Wellness, Rise AM, Reset PM, D3+, PhysIQ Fat Burn, PhysIQ Prebiotic, MindBody GLP-1 System, Petandim for Dogs, Axio, and TrueScience skincare lines through its website and independent consultants. The current price is $6.65 with a market capitalization of $83.9M, and the stock is ranked 4291.
The price outlook is mixed over the near term, with a defined 30-day range and a multi-year forecast showing varied sentiment from neutral to bullish and progressively higher average prices in later years.
A major floor 51.9% below — a decisive break under it would weaken the trend.
The nearest floor, 3.2% below — buyers have tended to step in here.
The nearest ceiling, 71.5% above — a clean break opens room to run.
A major ceiling 97.4% above — clearing it would confirm fresh momentum.
Key LFVN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LFVN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.25 | Sell | $6.25 | Sell |
| MA 10 | $6.28 | Sell | $6.34 | Sell |
| MA 20 | $6.58 | Sell | $6.59 | Sell |
| MA 50 | $6.65 | Sell | $6.51 | Sell |
| MA 100 | $5.66 | Buy | $6.33 | Sell |
| MA 200 | $6.37 | Sell | $7.09 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.79 | Neutral |
| Stoch RSI (14) | 42.31 | Neutral |
| CCI (20) | -40.90 | Neutral |
| Williams %R (14) | -71.93 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | 0.97 | Buy |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 28.07 | Neutral |
| TRIX (15) | -0.41 | Sell |
| Awesome (5,34) | -1.06 | Sell |
| Ultimate (7,14,28) | 47.43 | Neutral |
| Momentum (10) | -0.41 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 6.24 | Buy |
| ADX (14) | 17.70 | Neutral |
| ATR (14) | 0.25 | Info |
The 30-day technical picture shows a bullish stance overall, with an RSI of 50. The 50-day simple moving average is $6.38, and the 200-day simple moving average is $6.60. The stock sits above a support level of $5.12 and below a resistance level of $10.70. In the last 30 days, the price ranged from $4.55 to $9.71, indicating meaningful near-term volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.02 | $6.24 | $8.81 | 0% | Neutral | |
| $5.98 | $7.95 | $11.36 | +27% | Bullish | |
| $5.82 | $8.12 | $12.25 | +30% | Bullish | |
| $6.70 | $9.72 | $15.29 | +56% | Bullish | |
| $7.83 | $11.78 | $19.18 | +89% | Bullish | |
| $10.52 | $16.36 | $27.46 | +162% | Bullish | |
| $13.35 | $21.41 | $36.92 | +243% | Bullish | |
| $12.48 | $20.64 | $36.45 | +231% | Bullish | |
| $13.25 | $22.54 | $40.70 | +261% | Bullish | |
| $15.09 | $26.40 | $48.64 | +323% | Bullish | |
| $24.37 | $48.65 | $97.45 | +680% | Bullish | |
| $47.72 | $106.05 | $239.31 | +16.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.02 | $6.24 | $7.64 | +0.00% |
| August 2026 | $5.44 | $6.52 | $8.11 | +4.56% |
| September 2026 | $5.28 | $6.41 | $8.11 | -1.79% |
| October 2026 | $5.06 | $6.19 | $7.95 | -3.33% |
| November 2026 | $5.21 | $6.43 | $8.35 | +3.85% |
| December 2026 | $5.39 | $6.71 | $8.81 | +4.29% |
Click any year to see its month-by-month LFVN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
LifeVantage Corporation's 2026 outlook centres on $6.24, within a $4.02 to $8.81 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, LFVN could reach as high as $11.36, with a base case around $7.95 and support toward $5.98 — roughly +27% from $6.24. Momentum favours further upside here.
Expect LFVN to range from $5.82 to $12.25 through 2028. The $8.12 average target implies a +30% move from current prices. That is up +2% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The LFVN price prediction for 2029 points to an average of $9.72 (low $6.70, high $15.29) — a potential gain of +56% on today's $6.24. Momentum favours further upside here.
In 2030, LFVN is projected to trade between $7.83 and $19.18, averaging $11.78 — a potential gain of +89% from today's $6.24. That is up +21% on the projected 2029 average. Buyers look set to stay in control over this stretch.
LifeVantage Corporation's 2031 outlook centres on $16.36, within a $10.52 to $27.46 range. That is up +39% on the projected 2030 average. That marks a +162% change versus current levels. Momentum favours further upside here.
By 2032, LFVN could reach as high as $36.92, with a base case around $21.41 and support toward $13.35 — roughly +243% from $6.24. Buyers look set to stay in control over this stretch.
Expect LFVN to range from $12.48 to $36.45 through 2033. The $20.64 average target implies a +231% move from current prices. That is -4% versus the projected 2032 average. Momentum favours further upside here.
The LFVN price prediction for 2034 points to an average of $22.54 (low $13.25, high $40.70) — a potential gain of +261% on today's $6.24. Buyers look set to stay in control over this stretch.
In 2035, LFVN is projected to trade between $15.09 and $48.64, averaging $26.40 — a potential gain of +323% from today's $6.24. That is up +17% on the projected 2034 average. Momentum favours further upside here.
LifeVantage Corporation's 2040 outlook centres on $48.65, within a $24.37 to $97.45 range. That is up +84% on the projected 2035 average. That marks a +680% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, LFVN could reach as high as $239.31, with a base case around $106.05 and support toward $47.72 — roughly +16.0x from $6.24. Momentum favours further upside here.
Investing $1,000 in LFVN today (≈ 160.25641 LFVN) could be worth
$16,994.82
+$15,994.82 (+1599%) by 2050 · US Dollar
Based on the average projected LFVN price of $106.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LFVNwould be worth at today's price.
$1,000 invested in LFVN on Jul 10, 2025 (≈ 80.840744 LFVN) would be worth
$504.45
-$495.55 (-49.6%) today · 0.50× · US Dollar
Based on a LFVN entry price of $12.37 vs. today's $6.24.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.22 | $1,003.22 | +0.3% |
| 1 month ago | $9.48 | $658.23 | -34.2% |
| 3 months ago | $4.15 | $1,503.61 | +50.4% |
| 6 months ago | $6.79 | $919 | -8.1% |
| 1 year ago | $12.37 | $504.45 | -49.6% |
| All time (5.0y) ago | $6.5 | $960 | -4.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LFVN forecast.
Our base-case forecast reaches $12.00 around 2031.
Implied market cap at $12.00: $151.39M
The multi-year forecast presents a rising trajectory with year-by-year estimates. For 2026, the min is $4.02, the avg is $6.65, the max is $9.45, with a 0% ROI and neutral sentiment. In 2027, the avg rises to $8.05 with a max of $12.03 and a 21% ROI, with bullish sentiment.
The 2028 forecast shows an avg of $7.93 and a max of $12.62 (19.3% ROI), with neutral sentiment. The 2029 outlook indicates an avg of $8.76, a max of $14.63, and a 31.7% ROI, with bullish sentiment. By 2030, the avg reaches $10.95 and the max $19.04, delivering a 64.7% ROI and bullish sentiment.
The path continues higher through 2031 ($16.05 avg, $28.88 max, 141.4% ROI), 2032 ($20.30 avg, $37.65 max, 205.3% ROI), 2033 ($19.07 avg, $36.34 max, 186.7% ROI), 2034 ($21.07 avg, $41.17 max, 216.8% ROI), and 2035 ($23.30 avg, $46.58 max, 250.4% ROI) with bullish sentiment. The forecast highlights very strong upside for 2040 (avg $43.95, max $96.55, 560.9% ROI) and 2050 (avg $88.21, max $202.87, 1226.4% ROI), both bullish. These figures are estimates and reflect potential price paths, not guarantees, and are prone to uncertainty and market risk.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $10.95 with a low of $6.76 and a high of $19.04, representing a 64.7% ROI and bullish sentiment.
The forecast shows neutral sentiment in 2026 and 2028, then bullish sentiment from 2027 onward, with rising average prices and notable long‑term upside (e.g., 2030 avg $10.95 and 2050 avg $88.21; ROIs up to 1226.4%). These are estimates, not guarantees.
Yes, the 2050 max forecast is $202.87, which surpasses $100. The 2040 max is $96.55, which is below $100, so the higher figure occurs in the 2050 horizon.
Current price is $6.65 and market cap is $83.9M.
The 2027 forecast has an average price of $8.05 with a min of $5.82 and a max of $12.03, and a 21% ROI with bullish sentiment.
LifeVantage Corporation Community Discussion
0Share your LifeVantage Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.